However, despite being a relatively low-intensity intervention, it did seemingly result in improvements in secondary and tertiary outcomes relevant to T2DM risk: 2-hour insulin, triglycerides, and fasting plasma glucose ≥6.1 mmol/L. This evidence concerns the gene INS and type 2 diabetes mellitus.